Who Exports Betadine from India — 92 Suppliers Behind a $7.5M Market
India's betadine export market is supplied by 92 active exporters who collectively shipped $7.5M across 1,830 shipments. WIN-MEDICARE PRIVATE LIMITED leads with a 50.9% market share, followed by MAPAEX CONSUMER HEALTHCARE PRIVATE LIMITED and MODI-MUNDIPHARMA PRIVATE LIMITED. The top 5 suppliers together control 93.6% of total export value, reflecting a concentrated market structure.
Top Betadine Exporters from India — Ranked by Export Value
WIN-MEDICARE PRIVATE LIMITED is the leading betadine exporter from India, holding a 50.9% share of the $7.5M market across 1,830 shipments from 92 exporters. The top 5 suppliers — WIN-MEDICARE PRIVATE LIMITED, MAPAEX CONSUMER HEALTHCARE PRIVATE LIMITED, MODI-MUNDIPHARMA PRIVATE LIMITED, WIN MEDICARE PRIVATE LIMITED, MAKSON HEALTH CARE PRIVATE LIMITED — collectively control 93.6% of total export value, indicating a highly concentrated market. Individual shares are: WIN-MEDICARE PRIVATE LIMITED (50.9%), MAPAEX CONSUMER HEALTHCARE PRIVATE LIMITED (29.2%), MODI-MUNDIPHARMA PRIVATE LIMITED (5.2%), WIN MEDICARE PRIVATE LIMITED (5.0%), MAKSON HEALTH CARE PRIVATE LIMITED (3.3%).
Top Betadine Exporters from India
Ranked by export value · 92 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | WIN-MEDICARE PRIVATE LIMITED BETADINE STD.MICRO.SOL.10%USP 500MLPOV.BETADINE GARGLE 1%POVIDONE IODINE USP 1.BETADINE SURGICAL SCRUB 7.5%USPBOTTLE O | $3.8M | 3 | 50.9% |
| 2 | MAPAEX CONSUMER HEALTHCARE PRIVATE LIMITED ANAESTHETIC LOZENGES - BETADINE ANAESTHEMEDICATED LOZENGES - BETADINE LOZENGES -MEDICATED LOZENGES. BETADINE THROATAID L | $2.2M | 6 | 29.2% |
| 3 | MODI-MUNDIPHARMA PRIVATE LIMITED BETADINE STD.MICRO.SOL.10%USP 500MLPOV.BETADINE GARGLE 1%POVIDONE IODINE USP 1.BETADINE GARGLE & MOUTHWASH 1%POVIDONE I | $394.6K | 6 | 5.2% |
| 4 | WIN MEDICARE PRIVATE LIMITED BETADINE STD.MICRO.SOL.10%USP 500MLPOV.BETADINE GARGLE 1%POVIDONE IODINE USP 1.BETADINE SURGICAL SCRUB 7.5%USPBOTTLE O | $380.3K | 2 | 5.0% |
| 5 | MAKSON HEALTH CARE PRIVATE LIMITED ANAESTHETIC LOZENGES - BETADINE ANAESTHEANAESTHETIC LOZENGES BETADINE ANAESTHEMEDICATED LOZENGES LOZENGES BETADINE S | $246.6K | 1 | 3.3% |
| 6 | MODI MUNDIPHARMA PRIVATE LIMITED BETADINE STD.MICRO.SOL.10%USP 500MLPOV.BETADINE GARGLE 1%POVIDONE IODINE USP 1.BETADINE GARGLE & MOUTHWASH 1%POVIDONE I | $103.9K | 3 | 1.4% |
| 7 | CAPSTONE EXPORT & IMPORT BETADINE GARGLE SOLUTIONBETADINE SOLUTIONBETADINE VAGINAL PESSARIES | $87.6K | 1 | 1.2% |
| 8 | KOMAL EXPORTERS BETADINE OINTMENT 10%POVIDONE IODINE OIBETADINE OINTMENT 10% (POVI.IODINE OINTMBETADINE GARGLE 1% POVIDONE IODINE USP 1 | $42.3K | 1 | 0.6% |
| 9 | GET EXPORTS & IMPORTS SHOP BETADINE OINTMENT 10%POVIDONE IODINE OIBETADINE OINTMENT 10% (POVI.IODINE OINTMBETADINE GARGLE 1% POVIDONE IODINE USP 1 | $37.1K | 1 | 0.5% |
| 10 | TRANSGLOBAL ODYSSEY PRIVATE LIMITED | $17.2K | 1 | 0.2% |
| 11 | LOB INTERNATIONAL BETADINE STD.MICRO.SOL.10%USP 500MLPOV.BETADINE GARGLE 1%POVIDONE IODINE USP 1.BETADINE GARGLE & MOUTHWASH 1%POVIDONE I | $11.7K | 28 | 0.2% |
| 12 | FINESSE MARKET LINK PRIVATE LIMITED BETADINE OINTMENT 10%POVIDONE IODINE OIBETADINE OINTMENT 10% (POVI.IODINE OINTMBETADINE GARGLE 1% POVIDONE IODINE USP 1 | $10.9K | 1 | 0.1% |
| 13 | N CHIMANLAL ENTERPRISES ANAESTHETIC LOZENGES - BETADINE ANAESTHEMEDICATED LOZENGES - BETADINE LOZENGES -MEDICATED LOZENGES. BETADINE THROATAID L | $8.9K | 7 | 0.1% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Betadine exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Modi-Mundipharma Private Limited | Not Listed | Yes (as of December | No | Not verified | WHO-GMP certification confirmed by CDSCO on December 1, 2022. |
| Win-Medicare Private Limited | Not Listed | Yes (as of December | No | Not verified | WHO-GMP certification confirmed by CDSCO on December 1, 2022. |
TransData Nexus reviewed the regulatory standing of 2 leading Betadine exporters from India. 0 hold US FDA facility approvals, 2 maintain WHO-GMP certification, and 0 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Betadine sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for active pharmaceutical ingredients (APIs) and bulk drug production. The city hosts Genome Valley, India's first biotech cluster, and is home to over 800 pharmaceutical companies, including industry leaders such as Dr. Reddy’s Laboratories, Aurobindo Pharma, and Divi’s Laboratories. The presence of advanced research and development infrastructure, coupled with a skilled talent pool from institutions like the National Institute of Pharmaceutical Education and Research (NIPER) and the Indian Institute of Chemical Technology (IICT), makes Hyderabad a prime location for sourcing APIs essential for Betadine production.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its robust pharmaceutical formulations industry. Gujarat contributes nearly 28% of India's pharmaceutical production and houses major companies such as Zydus Cadila, Intas Pharmaceuticals, Torrent Pharmaceuticals, and Cadila Pharmaceuticals. The region's well-established infrastructure, including ports, roads, and utilities, supports efficient manufacturing and distribution of finished pharmaceutical products. This makes it an ideal location for sourcing formulated Betadine products ready for export.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt in Maharashtra serves as a critical export gateway for pharmaceutical products. With 929 pharmaceutical units, Maharashtra is a significant contributor to India's pharmaceutical exports. The region's proximity to major ports like Jawaharlal Nehru Port Trust (JNPT) facilitates seamless international shipping. Companies in this cluster benefit from well-developed logistics and regulatory frameworks, ensuring compliance with international standards for products like Betadine.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi and Nalagarh in Himachal Pradesh form one of Asia's largest pharmaceutical hubs, housing over 550 pharmaceutical units. The region's growth has been propelled by favorable tax incentives and a conducive business environment. Baddi's strategic location near the borders of Himachal Pradesh, Punjab, and Haryana, along with its robust infrastructure, makes it a viable option for cost-effective manufacturing of Betadine products.
5Sourcing Recommendations
- Diversify Supplier Base: While WIN-MEDICARE PRIVATE LIMITED is a major supplier, consider engaging with other manufacturers in different clusters to mitigate supply chain risks.
- Leverage Regional Specializations: Source APIs from Hyderabad for quality raw materials and formulations from Ahmedabad-Vadodara to capitalize on their respective strengths.
- Optimize Logistics: Utilize the Mumbai-Thane-Raigad region's export infrastructure for efficient international distribution of Betadine products.
- Evaluate Cost Benefits: Assess the financial advantages of manufacturing in Baddi-Nalagarh due to tax incentives and lower operational costs.
By strategically sourcing from these diverse pharmaceutical clusters, TransData Nexus can enhance the resilience and efficiency of its Betadine supply chain.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Betadine exporters from India
WIN-MEDICARE PRIVATE LIMITED — WIN-MEDICARE expands production capacity to meet rising Betadine demand
In February 2024, WIN-MEDICARE PRIVATE LIMITED increased its manufacturing capacity to address the growing demand for Betadine products. This expansion aims to enhance supply chain efficiency and meet both domestic and international market needs. - IMPACT: The capacity expansion is expected to strengthen WIN-MEDICARE's position in the Betadine export market, potentially increasing its export volume.
Impact: The capacity expansion is expected to strengthen WIN-MEDICARE's position in the Betadine export market, potentially increasing its export volume.
MAPAEX CONSUMER HEALTHCARE PRIVATE LIMITED — MAPAEX partners with international distributor to expand Betadine reach
In September 2023, MAPAEX CONSUMER HEALTHCARE PRIVATE LIMITED entered into a strategic partnership with an international distributor to broaden the availability of Betadine products in new markets. This collaboration focuses on enhancing distribution channels and market penetration. - IMPACT: The partnership is anticipated to increase MAPAEX's Betadine exports, contributing to higher market share in targeted regions.
Impact: The partnership is anticipated to increase MAPAEX's Betadine exports, contributing to higher market share in targeted regions.
MODI-MUNDIPHARMA PRIVATE LIMITED — MODI-MUNDIPHARMA receives CDSCO approval for new Betadine formulation
In June 2023, MODI-MUNDIPHARMA PRIVATE LIMITED obtained approval from the Central Drugs Standard Control Organisation (CDSCO) for a new formulation of Betadine. This approval allows the company to manufacture and market the product domestically and for export. - IMPACT: The regulatory approval enables MODI-MUNDIPHARMA to diversify its Betadine product offerings, potentially boosting export sales.
Impact: The regulatory approval enables MODI-MUNDIPHARMA to diversify its Betadine product offerings, potentially boosting export sales.
Common Questions — Betadine Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which betadine supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, WIN-MEDICARE PRIVATE LIMITED leads with 626 recorded shipments worth $3.8M. MAPAEX CONSUMER HEALTHCARE PRIVATE LIMITED (88 shipments) and MODI-MUNDIPHARMA PRIVATE LIMITED (99 shipments) are also established high-volume exporters.
Q How many betadine manufacturers are there in India?
India has 92 active betadine exporters with a combined export market of $7.5M across 1,830 shipments to 68 countries. The top 5 suppliers hold 93.6% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for betadine from India?
Average FOB unit price: $2.68 per unit, ranging from $0.02 to $255.46. Average shipment value: $4.1K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 92 verified Indian exporters of Betadine ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 1,830 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 68 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,830 Verified Shipments
92 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists